AAAAAA
Results:
1-14
|
Results: 14
Authors:
EVANGELISTA R
PERANI G
RAPITI F
ARCHIBUGI D
Citation: R. Evangelista et al., NATURE AND IMPACT OF INNOVATION IN MANUFACTURING-INDUSTRY - SOME EVIDENCE FROM THE ITALIAN INNOVATION SURVEY, Research policy, 26(4-5), 1997, pp. 521-536
Authors:
BELLOMO G
MARCHESI E
PERANI G
MAGGI E
PALLADINI G
Citation: G. Bellomo et al., ALPHA-TOCOPHEROL SUPPLEMENTATION IN HYPERTENSION AND HYPERCHOLESTEROLEMIA, Atherosclerosis, 135, 1997, pp. 2-2
Authors:
MARTIGNONI A
TINELLI C
MARCHESI E
FALASCHI F
MAGGI E
PERANI G
Citation: A. Martignoni et al., RISK-FACTORS FOR INTIMA-MEDIA THICKENING IN UNTREATED HYPERTENSIVES, Atherosclerosis, 134(1-2), 1997, pp. 98-98
Authors:
PERANI G
PALLADINI G
RESASCO T
FRATTONI A
TRAVERSA B
BELLOMO G
Citation: G. Perani et al., SERUM PARAOXONASE ACTIVITY AND EARLY ATHEROSCLEROSIS IN HYPERTENSIVE AND HYPERCHOLESTEROLEMIC PATIENTS, Atherosclerosis, 134(1-2), 1997, pp. 165-165
Authors:
BRAZZELLI V
DISTANTE F
PERANI G
BERARDESCA E
Citation: V. Brazzelli et al., EFFECTS OF SYSTEMIC TREATMENT WITH STATINS ON SKIN BARRIER FUNCTION AND STRATUM-CORNEUM WATER-HOLDING CAPACITY, Dermatology, 192(3), 1996, pp. 214-216
Authors:
MAGGI E
MARCHESI E
COVINI D
NEGRO C
PERANI G
BELLOMO G
Citation: E. Maggi et al., PROTECTIVE EFFECTS OF CARVEDILOL, A VASODILATING BETA-ADRENOCEPTOR BLOCKER, AGAINST IN-VIVO LOW-DENSITY-LIPOPROTEIN OXIDATION IN ESSENTIAL-HYPERTENSION, Journal of cardiovascular pharmacology, 27(4), 1996, pp. 532-538
Authors:
CAMPANA C
IACONA I
REGAZZI MB
GAVAZZI A
PERANI G
RADDATO V
MONTEMARTINI C
VIGANO M
Citation: C. Campana et al., EFFICACY AND PHARMACOKINETICS OF SIMVASTATIN IN HEART-TRANSPLANT RECIPIENTS, The Annals of pharmacotherapy, 29(3), 1995, pp. 235-239
Authors:
MAGGI E
FALASCHI F
PERANI G
FRATTONI A
FINARDI G
BELLOMO G
Citation: E. Maggi et al., LOW-DENSITY-LIPOPROTEIN OXIDATION CORRELA TION BETWEEN DECREASED RESISTANCE IN-VITRO AND ENHANCED OXIDATION IN-VIVO, La Presse medicale, 24(9), 1995, pp. 431-436
Authors:
BERARDESCA E
DISTANTE F
BRAZZELLI V
VIGNOLI GP
PERANI G
Citation: E. Berardesca et al., EFFECTS OF SYSTEMIC TREATMENT WITH STATINS ON SKIN BARRIER FUNCTION, Journal of investigative dermatology, 104(4), 1995, pp. 656-656
Authors:
MARCHESI E
PERANI G
FALASCHI F
NEGRO C
CATALANO O
RAVETTA V
FINARDI G
Citation: E. Marchesi et al., METABOLIC RISK-FACTORS IN WHITE COAT HYPERTENSIVES, Journal of human hypertension, 8(7), 1994, pp. 475-479
Authors:
MAGGI E
PERANI G
FALASCHI F
FRATTONI A
MARTIGNONI A
FINARDI G
STEFANO PL
SIMEONE F
PAOLINI G
DEVECCHI E
GROSSI A
BELLOMO G
Citation: E. Maggi et al., ANTOANTIBODIES AGAINST OXIDIZED LOW-DENSI TY LIPOPROTEINS IN PATIENTSWITH CORONARY ATHEROSCLEROSIS, La Presse medicale, 23(25), 1994, pp. 1158-1162
Authors:
MAGGI E
BELLAZZI R
FALASCHI F
FRATTONI A
PERANI G
FINARDI G
GAZO A
NAI M
ROMANINI D
BELLOMO G
Citation: E. Maggi et al., ENHANCED LDL OXIDATION IN UREMIC PATIENTS - AN ADDITIONAL MECHANISM FOR ACCELERATED ATHEROSCLEROSIS, Kidney international, 45(3), 1994, pp. 876-883
Authors:
REGAZZI MB
IACONA I
CAMPANA C
GAVAZZI A
VIGANO M
PERANI G
Citation: Mb. Regazzi et al., CLINICAL EFFICACY AND PHARMACOKINETICS OF HMG-COA REDUCTASE INHIBITORS IN HEART-TRANSPLANT PATIENTS TREATED WITH CYCLOSPORINE-A, Transplantation proceedings, 26(5), 1994, pp. 2644-2645
Authors:
REGAZZI MB
IACONA I
CAMPANA C
RADDATO V
LESI C
PERANI G
GAVAZZI A
VIGANO M
Citation: Mb. Regazzi et al., ALTERED DISPOSITION OF PRAVASTATIN FOLLOWING CONCOMITANT DRUG-THERAPYWITH CYCLOSPORINE-A IN TRANSPLANT RECIPIENTS, Transplantation proceedings, 25(4), 1993, pp. 2732-2734
Risultati:
1-14
|